NOLC1 and hepatocellular carcinoma: The other frequently detected fusion transcripts in the pre-treatment HCC serum samples were PTEN–NOLC1 and CCNH–C5orf30, accounting for 57.4% (35/61) and 55.7% (34/61) of the total samples, respectively.